InsiderDB

Lobbying disclosures · Lobbying report

COR: third_quarter 2026 lobbying report

Issues related to health care and pharmaceutical industry

Follow COR
Became public
Oct 20, 2026, 3:06 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 5:39 PM EST

Why this is connected

Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).

Reported lobbying amounts

Income: $75,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/d8cf0f3a-687b-4c0d-89eb-0a8059e3c1d0/","filing_uuid":"d8cf0f3a-687b-4c0d-89eb-0a8059e3c1d0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d8cf0f3a-687b-4c0d-89eb-0a8059e3c1d0/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David J. Schiappa","dt_posted":"2026-10-20T15:06:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW","registrant_address_2":"Suite 825","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":12675,"url":"https://lda.gov/api/v1/registrants/12675/","house_registrant_id":31811,"name":"THE DUBERSTEIN GROUP INC.","description":"Consulting","address_1":"325 7th Street NW","address_2":"Suite 825","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID J. SCHIAPPA","contact_telephone":"+1 202-728-1100","dt_updated":"2026-07-24T11:16:57.603169-04:00"},"client":{"id":66748,"url":"https://lda.gov/api/v1/clients/66748/","client_id":66748,"name":"CENCORA, INC.","general_description":"American drug wholesale company and a contract research organization.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to health care and pharmaceutical industry","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79182,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"R","last_name":"HOWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71388,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":"KATE","middle_name":"WINKLER","last_name":"KEATING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101351,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"KELLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59537,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"J","last_name":"SCHIAPPA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in COR

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.